SCOPUS 정보 검색 플랫폼

American Journal of Clinical Pathology

Volumn 137, Issue 4, 2012, Pages 572-574

Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy

(4) Avecilla, Scott T a,b Ferrell, Chris a Chandler, Wayne L a,c Reyes, Morayma a

a UNIVERSITY OF WASHINGTON (United States)

b NEW YORK BLOOD CENTER (United States)

c HOUSTON METHODIST HOSPITAL (United States)

Author keywords

Dabigatran; Thrombin inhibitor; Thrombin time

Indexed keywords

DABIGATRAN ETEXILATE; ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DILUTED THROMBIN TIME ASSAY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HUMAN; PRIORITY JOURNAL; THROMBIN TIME; DOSE RESPONSE; HEART ATRIUM FIBRILLATION; STROKE;

ANTITHROMBIN PROTEINS; ATRIAL FIBRILLATION; BENZIMIDAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PYRIDINES; STROKE; THROMBIN TIME;

EID: 84860548394 PISSN: 00029173 EISSN: 19437722 Source Type: Journal
DOI: 10.1309/AJCPAU7OQM0SRPZQ Document Type: Article

Times cited : (75)

References (6)

1
- 34447503698
- Monitoring direct thrombin inhibitors with a plasma diluted thrombin time
- Love JE, Ferrell C, Chandler WL. Monitoring direct thrombin inhibitors with a plasma diluted thrombin time. Thromb Haemost. 2007;98:234-242.
- (2007) Thromb Haemost , vol.98 , pp. 234-242
- Love, J.E.¹ Ferrell, C.² Chandler, W.L.³

2
- 84860911695
- Accessed July 13, 2011
- Aniara. Aniara Dabigatran (Pradaxa) Plasma Calibrator product page. http://www.aniara.com/PROD/A222801.html. Accessed July 13, 2011.
- Aniara Dabigatran (Pradaxa) Plasma Calibrator Product Page

3
- 77957696662
- Dabigatran: An oral novel potent reversible nonpeptide inhibitor of thrombin
- Eisert WG, Hauel N, Stangier J, et al.Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin. Arterioscler Thromb Vasc Biol. 2010;30:1885-1889.
- (2010) Arterioscler Thromb Vasc Biol , vol.30 , pp. 1885-1889
- Eisert, W.G.¹ Hauel, N.² Stangier, J.³

4
- 77953168824
- Dabigatran etexilate: A novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity
- van Ryn J, Stangier J, Haertter S, et al.Dabigatran etexilate: a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010;103:1116-1127.
- (2010) Thromb Haemost , vol.103 , pp. 1116-1127
- Van Ryn, J.¹ Stangier, J.² Haertter, S.³

5
- 77952167209
- Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor
- Stangier J, Clemens A. Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor. Clin Appl Thromb Hemost. 2009;15(suppl 1):9S-16S.
- (2009) Clin Appl Thromb Hemost , vol.15 , Issue.SUPPL. 1
- Stangier, J.¹ Clemens, A.²

6
- 34548031359
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
- DOI 10.1111/j.1365-2125.2007.02899.x
- Stangier J, Rathgen K, Stähle H, et al.The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol. 2007;64:292-303. (Pubitemid 47283865)
- (2007) British Journal of Clinical Pharmacology , vol.64 , Issue.3 , pp. 292-303
- Stangier, J.¹ Rathgen, K.² Stahle, H.³ Gansser, D.⁴ Roth, W.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.